See also
PDF Report 0001176309_2012_Oramed_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.0, 'aggregate_val': 0, 'exp_sum': 1516838, 'exp_to_value': {'LiabilitiesCurrent': 644425, 'LiabilitiesNoncurrent': 872413, 'remainder_Liabilities': 0}} |
| warning | Ignoring company because Liabilities is zero | pre-agg | {'balance_sheet': {'company_id': '0001176309', 'EntityCommonStockSharesOutstanding': 86505020, 'Assets': 5294851, 'AssetsCurrent': 5276476, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 90218, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 0, 'LiabilitiesAndStockholdersEquity': 5294851, 'LiabilitiesCurrent': 644425, 'LiabilitiesNoncurrent': 872413, 'NetIncome': -3344478, 'PropertyPlantAndEquipmentNet': 4768, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 13607, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 90218, 'remainder_Liabilities': -1516838, 'remainder_LiabilitiesAndStockholdersEquity': 3778013, 'remainder_NetIncome': -3254260, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |